Kyivstar acquires Ukrainian digital pharmacy platform Tabletki.ua
Kyivstar acquires Ukrainian digital pharmacy platform Tabletki.ua
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Kyivstar acquires Ukrainian digital pharmacy platform Tabletki.ua
'It's not an easy pill to take': The first highly anticipated GLP-1 pill is here, but physicians aren't sure it has the staying power of the injections
Tech-led rally in the S&P 500 will resume, Capital Economics says
The changes come as the wider retail-pharmacy market has been upended in recent years.
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk's Wegovy ora...
Nvidia and Caterpillar were the Dow's top gainers, rising nearly 8% and 7.1% respectively. The S&P 500 and the Nasdaq composite each gained roughly 2%, fol...
Weight-loss drugs to compete on biggest stage with Super Bowl ads
Nearly 30% of people surveyed say Social Security eligibility was a major reason they decided to retire.
The dark web drug market used crypto for payments, but blockchain transaction tracing helped the FBI identify its creator, who was sentenced to 30 years in...
Pfizer shares edge up ahead of quarterly earnings report